Login / Signup

Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.

Atsushi ObaY H Andrew WuKathryn L ColbornSana D KaramCheryl MeguidMohammed H Al-MusawiQuoc Riccardo BaoAna L GleisnerSteven AhrendtRichard D SchulickMarco Del Chiaro
Published in: The British journal of surgery (2022)
This study failed to show a survival benefit for NACRT over NAC alone, despite its association with negative margin resection. The significantly higher mortality in NACRT warrants further investigation into its efficacy in the treatment of pancreatic cancer.
Keyphrases
  • neoadjuvant chemotherapy
  • locally advanced
  • lymph node
  • sentinel lymph node
  • transcription factor
  • type diabetes
  • risk factors
  • squamous cell carcinoma
  • cardiovascular disease
  • radiation therapy
  • adverse drug
  • drug induced